Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Financial Flexibility Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of CN¥3.68 Billion (operating CF CN¥2.40 Billion minus capex CN¥1.28 Billion) represents 0% of total liabilities (CN¥57.97 Billion). Also explore 600196 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Check Shanghai Fosun Pharmaceutical Group Co L PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Shanghai Fosun Pharmaceutical Group Co L.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥10.45 Billion | CN¥6.01 Billion | CN¥57.97 Billion | ▲ +16.7% |
| 2024 | 0.15x | CN¥8.89 Billion | CN¥4.48 Billion | CN¥57.53 Billion | ▼ -9.5% |
| 2023 | 0.17x | CN¥9.70 Billion | CN¥4.36 Billion | CN¥56.85 Billion | ▼ -10.4% |
| 2022 | 0.19x | CN¥10.11 Billion | CN¥4.22 Billion | CN¥53.05 Billion | ▼ -4.1% |
| 2021 | 0.20x | CN¥8.92 Billion | CN¥3.95 Billion | CN¥44.92 Billion | ▲ +6.7% |
| 2020 | 0.19x | CN¥7.02 Billion | CN¥2.58 Billion | CN¥37.70 Billion | ▼ -4.4% |
| 2019 | 0.19x | CN¥7.18 Billion | CN¥3.22 Billion | CN¥36.92 Billion | ▲ +17.4% |
| 2018 | 0.17x | CN¥6.13 Billion | CN¥2.95 Billion | CN¥36.96 Billion | ▲ +12.4% |
| 2017 | 0.15x | CN¥4.75 Billion | CN¥2.58 Billion | CN¥32.23 Billion | ▼ -32.3% |
| 2016 | 0.22x | CN¥4.03 Billion | CN¥2.11 Billion | CN¥18.52 Billion | ▲ +33.6% |
| 2015 | 0.16x | CN¥2.86 Billion | CN¥1.62 Billion | CN¥17.53 Billion | ▲ +14.0% |
| 2014 | 0.14x | CN¥2.32 Billion | CN¥1.20 Billion | CN¥16.23 Billion | ▼ -17.7% |
| 2013 | 0.17x | CN¥2.05 Billion | CN¥1.01 Billion | CN¥11.81 Billion | ▼ -2.9% |
| 2012 | 0.18x | CN¥1.83 Billion | CN¥665.52 Million | CN¥10.20 Billion | ▲ +75.5% |
| 2011 | 0.10x | CN¥1.11 Billion | CN¥316.65 Million | CN¥10.92 Billion | ▲ +39.6% |
| 2010 | 0.07x | CN¥542.53 Million | CN¥203.36 Million | CN¥7.43 Billion | ▼ -45.2% |
| 2009 | 0.13x | CN¥609.93 Million | CN¥261.87 Million | CN¥4.58 Billion | ▼ -7.1% |
| 2008 | 0.14x | CN¥443.67 Million | CN¥233.04 Million | CN¥3.09 Billion | ▲ +31.1% |
| 2007 | 0.11x | CN¥341.18 Million | CN¥131.48 Million | CN¥3.12 Billion | ▼ -27.7% |
| 2006 | 0.15x | CN¥451.52 Million | CN¥184.91 Million | CN¥2.99 Billion | ▲ +2.8% |
| 2005 | 0.15x | CN¥410.95 Million | CN¥188.35 Million | CN¥2.79 Billion | ▼ -15.5% |
| 2004 | 0.17x | CN¥410.12 Million | CN¥205.10 Million | CN¥2.36 Billion | ▼ -7.5% |
| 2003 | 0.19x | CN¥414.19 Million | CN¥150.14 Million | CN¥2.20 Billion | ▲ +14.0% |
| 2002 | 0.17x | CN¥242.00 Million | CN¥102.47 Million | CN¥1.47 Billion | ▼ -30.4% |
| 2001 | 0.24x | CN¥209.66 Million | CN¥68.15 Million | CN¥884.68 Million | ▼ -68.5% |
| 2000 | 0.75x | CN¥265.05 Million | CN¥138.43 Million | CN¥352.61 Million | ▲ +30.1% |
| 1999 | 0.58x | CN¥116.19 Million | CN¥38.20 Million | CN¥201.15 Million | ▼ -43.4% |
| 1998 | 1.02x | CN¥118.80 Million | CN¥66.55 Million | CN¥116.36 Million | — |